3

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: September 2, 2011
Period of Report: September 1, 2011
Accession Number: 0001237899-11-000048

View Document ↗ View on SEC.gov ↗